We are live on
!
Find out more
Biogen
BIIB
BIIB
646 hedge funds and large institutions have $47.5B invested in Biogen in 2013 Q2 according to their latest regulatory filings, with 646 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
13% less call options, than puts
Call options by funds: $527M | Put options by funds: $606M
Holders
646
Holders Change
+646
Holders Change %
–
% of All Funds
21.08%
Holding in Top 10
29
Holding in Top 10 Change
+29
Holding in Top 10 Change %
% of All Funds
0.95%
New
646
Increased
–
Reduced
–
Closed
–
Calls
$527M
Puts
$606M
Net Calls
-$78.9M
Net Calls Change
-$78.9M
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
BIIB Hedge Fund Activity: Q2 2013 in Review
646 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q2 2013, worth a combined $47.5B.
Buyers outnumbered sellers: 646 funds opened new BIIB positions and 0 closed out — a net gain of 646 holders — while 0 added to existing stakes and 0 trimmed.
- 646 institutional investors held Biogen (BIIB) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $47.5B of Biogen stock for Q2 2013.
- 646 funds opened new Biogen positions in Q2 2013 and 0 closed out, a net change of +646 holders.
Based on aggregated 13F filings for Q2 2013.